An essential role for the circadian‐regulated gene Nocturnin in osteogenesis: the importance of local timekeeping in skeletal homeostasis

The role of circadian proteins in regulating whole‐body metabolism and bone turnover has been studied in detail and has led to the discovery of an elemental system for timekeeping involving the core genes Clock, Bmal1, Per, and Cry. Nocturnin (Noc; Ccrn4l), a peripheral circadian‐regulated gene has been shown to play a very important role in regulating adipogenesis by deadenylation of key mRNAs and intracytoplasmic transport of PPARγ. The role that it plays in osteogenesis has previously not been studied in detail. In this report we examined in vitro and in vivo osteogenesis in the presence and absence of Noc and show that loss of Noc enhances bone formation and can rescue rosiglitazone‐induced bone loss in mice. The circadian rhythm of Noc is likely to be an essential element of marrow stromal cell fate.

[1]  C. Green,et al.  Nocturnin Regulates Circadian Trafficking of Dietary Lipid in Intestinal Enterocytes , 2011, Current Biology.

[2]  K. Wagner,et al.  Mouse Knockout of the Cholesterogenic Cytochrome P450 Lanosterol 14α-Demethylase (Cyp51) Resembles Antley-Bixler Syndrome* , 2011, The Journal of Biological Chemistry.

[3]  A. Guntur,et al.  Conditional ablation of Pten in osteoprogenitors stimulates FGF signaling , 2011, Development.

[4]  M. Adamo,et al.  Nocturnin suppresses igf1 expression in bone by targeting the 3' untranslated region of igf1 mRNA. , 2010, Endocrinology.

[5]  A. Schilling,et al.  The Clock Genes Period 2 and Cryptochrome 2 Differentially Balance Bone Formation , 2010, PloS one.

[6]  C. Ackert-Bicknell,et al.  A circadian-regulated gene, Nocturnin, promotes adipogenesis by stimulating PPAR-γ nuclear translocation , 2010, Proceedings of the National Academy of Sciences.

[7]  C. Ackert-Bicknell,et al.  Nocturnin: a circadian target of Pparg‐induced adipogenesis , 2010, Annals of the New York Academy of Sciences.

[8]  Oren Froy,et al.  Metabolism and circadian rhythms--implications for obesity. , 2010, Endocrine reviews.

[9]  G. Stein,et al.  The osteogenic transcription factor runx2 controls genes involved in sterol/steroid metabolism, including CYP11A1 in osteoblasts. , 2009, Molecular endocrinology.

[10]  Jure Acimovic,et al.  CREM modulates the circadian expression of CYP51, HMGCR and cholesterogenesis in the liver. , 2008, Biochemical and biophysical research communications.

[11]  M. Wickens,et al.  Multifunctional deadenylase complexes diversify mRNA control , 2008, Nature Reviews Molecular Cell Biology.

[12]  D. Prockop,et al.  Concise Review: Mesenchymal Stem/Multipotent Stromal Cells: The State of Transdifferentiation and Modes of Tissue Repair—Current Views , 2007, Stem cells.

[13]  Joseph Fogerty,et al.  Loss of Nocturnin, a circadian deadenylase, confers resistance to hepatic steatosis and diet-induced obesity , 2007, Proceedings of the National Academy of Sciences.

[14]  J. Besharse,et al.  Immediate early response of the circadian polyA ribonuclease nocturnin to two extracellular stimuli. , 2007, RNA.

[15]  E. Wagner,et al.  The Molecular Clock Mediates Leptin-Regulated Bone Formation , 2005, Cell.

[16]  J. Gimble,et al.  Controlling the balance between osteoblastogenesis and adipogenesis and the consequent therapeutic implications. , 2004, Current opinion in pharmacology.

[17]  L. Suva,et al.  Bone is a target for the antidiabetic compound rosiglitazone. , 2004, Endocrinology.

[18]  Thomas D. Schmittgen,et al.  Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. , 2001, Methods.

[19]  J. Besharse,et al.  Identification of a novel vertebrate circadian clock-regulated gene encoding the protein nocturnin. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[20]  M J McLeod,et al.  Differential staining of cartilage and bone in whole mouse fetuses by alcian blue and alizarin red S. , 1980, Teratology.